SCHEMBL29430579

SCHEMBL29430579

CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(N)=O

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ NMUR2 Q9GZQ4 9/20 0.62
▸ NMUR1 Q9HB89 8/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11443809 0.91 SLC6A2 (0.67) NMUR2NMUR1
SCHEMBL29445676 0.90 SLC6A2 (0.64) NMUR2NMUR1
SCHEMBL29604581 0.89 NMUR2 (0.77) NMUR2NMUR1
SCHEMBL30234090 0.89 NMUR2 (0.55) NMUR2NMUR1
SCHEMBL38650937 0.88 NTSR1 (0.58) NMUR2NMUR1
SCHEMBL30987365 0.87 NMUR2 (0.57) NMUR2NMUR1
SCHEMBL30853506 0.86 NTSR2 (0.63) —
SCHEMBL31362752 0.86 OPRD1 (0.62) NMUR2NMUR1
SCHEMBL11443805 0.86 SLC6A2 (0.68) NMUR2NMUR1
SCHEMBL31020744 0.86 SLC6A2 (0.63) NMUR2NMUR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067715-A1 ANTIBODIES WITH IMPROVED STABILITY TO INTESTINAL DIGESTION, POLYNUCLEOTIDES THEREOF AND METHODS OF USE THEREOF TO TREAT DISEASE CIRCLE33 LLC (US) 2024-02-29 — — US disclosed
US-11891440-B2 Antibodies with improved stability to intestinal digestion, polynucleotides thereof and methods of use thereof to treat disease CIRCLE33 LLC (US) 2024-02-06 — — US disclosed
US-20220073602-A1 Antibodies with improved stability to intestinal digestion CIRCLE33 LLC 2022-03-10 — — US disclosed
Send feedback